MedPath

Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting

Completed
Conditions
Hepatitis B Virus
Allograft
Hematological Malignancies
Registration Number
NCT00876148
Lead Sponsor
Azienda Ospedaliera San Giovanni Battista
Brief Summary

The purpose of this study is to evaluate the risk of hepatitis B reactivation in patients undergoing allografting.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • All patients undergoing an allograft for hematological malignancies
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Azienda ospedaliera S Giovanni Battista

🇮🇹

Torino, Italy

© Copyright 2025. All Rights Reserved by MedPath